These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 21158414)
1. Uniformity of drug payload and its effect on stability of solid lipid nanoparticles containing an ester prodrug. Kim JK; Howard MD; Dziubla TD; Rinehart JJ; Jay M; Lu X ACS Nano; 2011 Jan; 5(1):209-16. PubMed ID: 21158414 [TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929 [TBL] [Abstract][Full Text] [Related]
3. In vivo real-time fluorescence visualization and brain-targeting mechanisms of lipid nanocarriers with different fatty ester:oil ratios. Wen CJ; Yen TC; Al-Suwayeh SA; Chang HW; Fang JY Nanomedicine (Lond); 2011 Nov; 6(9):1545-59. PubMed ID: 22077462 [TBL] [Abstract][Full Text] [Related]
5. Stability of lipid excipients in solid lipid nanoparticles. Radomska-Soukharev A Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589 [TBL] [Abstract][Full Text] [Related]
6. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles. Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY J Microencapsul; 2009 Dec; 26(8):734-47. PubMed ID: 19888882 [TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847 [TBL] [Abstract][Full Text] [Related]
8. A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery. Xu Y; Jin X; Ping Q; Cheng J; Sun M; Cao F; You W; Yuan D J Control Release; 2010 Sep; 146(3):299-308. PubMed ID: 20580913 [TBL] [Abstract][Full Text] [Related]
9. [Preparation and characterization of solid lipid nanoparticles of norcantharidin]. Tian HY; Zhai GX Zhong Yao Cai; 2007 Sep; 30(9):1146-8. PubMed ID: 18236763 [TBL] [Abstract][Full Text] [Related]
10. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Liu CH; Wu CT; Fang JY Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release. Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903 [TBL] [Abstract][Full Text] [Related]
12. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600 [TBL] [Abstract][Full Text] [Related]
13. Lipid nanoparticles as vitamin matrix carriers in liquid food systems: On the role of high-pressure homogenisation, droplet size and adsorbed materials. Shukat R; Relkin P Colloids Surf B Biointerfaces; 2011 Aug; 86(1):119-24. PubMed ID: 21524892 [TBL] [Abstract][Full Text] [Related]
14. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil. Sharma P; Ganta S; Denny WA; Garg S Int J Pharm; 2009 Feb; 367(1-2):187-94. PubMed ID: 18930127 [TBL] [Abstract][Full Text] [Related]
16. Alternative sample preparation prior to two-dimensional electrophoresis protein analysis on solid lipid nanoparticles. Göppert TM; Müller RH Electrophoresis; 2004 Jan; 25(1):134-40. PubMed ID: 14730578 [TBL] [Abstract][Full Text] [Related]
17. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation. Wacker M; Zensi A; Kufleitner J; Ruff A; Schütz J; Stockburger T; Marstaller T; Vogel V Int J Pharm; 2011 Jul; 414(1-2):225-32. PubMed ID: 21571055 [TBL] [Abstract][Full Text] [Related]
18. Chemical and structural investigation of lipid nanoparticles: drug-lipid interaction and molecular distribution. Anantachaisilp S; Smith SM; Treetong A; Pratontep S; Puttipipatkhachorn S; Ruktanonchai UR Nanotechnology; 2010 Mar; 21(12):125102. PubMed ID: 20182010 [TBL] [Abstract][Full Text] [Related]
19. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Kuo YC; Chung JF Colloids Surf B Biointerfaces; 2011 Apr; 83(2):299-306. PubMed ID: 21194902 [TBL] [Abstract][Full Text] [Related]
20. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. Kratz F J Control Release; 2008 Dec; 132(3):171-83. PubMed ID: 18582981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]